A phase 1b open-label dose-finding study of ustekinumab in young adults with type 1 diabetes.
Marwaha AK, Chow S, Pesenacker AM, Cook L, Sun A, Long SA, Yang JHM, Ward-Hartstonge KA, Williams E, Domingo-Vila C, Halani K, Harris KM, Tree TIM, Levings MK, Elliott T, Tan R, Dutz JP.
Marwaha AK, et al.
Immunother Adv. 2021 Nov 13;2(1):ltab022. doi: 10.1093/immadv/ltab022. eCollection 2022.
Immunother Adv. 2021.
PMID: 35072168
Free PMC article.